Some leading companies operating in the blood testing market include;
Danaher (Beckman Coulter Inc. and Radiometer)
F Hoffmann-La Roche Ltd
Abbott Laboratories
BioMerieux SA
Biomerica, Grifols
A.S, Becton
Dickinson and Company (BD)
Bio-Rad Laboratories Inc
Siemens Healthineers
Sinocare Inc (NIPRO Diagnostics)
Trinity Biotech
Thermo Fisher Scientific Inc
B. Braun Melsungen AG
Authors:
Mariam Faizullabhoy , Pratiksha Kamthe
Frequently Asked Questions (FAQ) :
Blood testing industry size was worth USD 74.9 billion in 2022 and is set to grow at over 6.5% CAGR from 2023 to 2032 attributed to the growing burden of chronic and infectious diseases globally.
Blood testing market from the complete blood count test segment reached USD 11.1 billion in 2022 and is poised to record substantial growth through 2032 owing to the increasing prevalence of non-communicable diseases.
North America accounted for more than 32.6% revenue share of the blood testing market in 2022 and is estimated to reach USD 43.4 billion by 2032 attributed to favorable reimbursement policies, robust healthcare infrastructure, and supportive government initiatives.
Danaher (Beckman Coulter Inc. and Radiometer), F Hoffmann-La Roche Ltd., Abbott Laboratories, BioMerieux SA., Biomerica, Grifols, A.S, Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc, Siemens Healthineers, Thermo Fisher Scientific Inc., and B. Braun Melsungen AG are some top companies